sorafenib has been researched along with carbon tetrachloride in 6 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (carbon tetrachloride) | Trials (carbon tetrachloride) | Recent Studies (post-2010) (carbon tetrachloride) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 8,804 | 11 | 2,582 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Deng, YR; Diehl, AM; Gershwin, ME; He, XS; Lian, ZX; Liu, CH; Liu, P; Lu, FT; Ma, HD; Tsuneyama, K; Wang, YH; Yang, W | 1 |
| Chen, Y; Duda, DG; Duyverman, AM; Hiddingh, L; Huang, P; Huang, Y; Jain, RK; Koppel, C; Lauwers, GY; Reiberger, T; Roberge, S; Samuel, R; Zhu, AX | 1 |
| Chen, Y; Chiang, T; Gao, DY; Lin, TsT; Liu, JY; Liu, YC; Sung, YC; Wan, D; Wang, L | 1 |
| Chen, DS; Chen, KF; Chen, LJ; Chen, PJ; Hu, TC; Huang, KW; Huang, YJ; Jao, P; Kao, JH; Liu, CH; Liu, CJ; Shiau, CW; Su, TH; Tai, WT; Tseng, TC; Wu, YM; Yang, HC; Yang, NJ | 1 |
| Chen, XF; Ji, S | 1 |
6 other study(ies) available for sorafenib and carbon tetrachloride
| Article | Year |
|---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.
Topics: Actins; Active Transport, Cell Nucleus; Animals; Carbon Tetrachloride; Cell Nucleus; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Gene Expression; Hepatocytes; Immunoblotting; Immunohistochemistry; Interleukin-6; Kinetics; Kupffer Cells; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Mice, Knockout; Niacinamide; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Sorafenib; STAT3 Transcription Factor; Tissue Inhibitor of Metalloproteinase-1 | 2013 |
Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice.
Topics: Animals; Carbon Tetrachloride; Carcinoma, Hepatocellular; CD11b Antigen; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Disease Models, Animal; Hepatocyte Growth Factor; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Mice; Mice, Inbred C3H; Mice, Knockout; Myeloid Cells; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins; Receptors, Chemokine; Receptors, CXCR4; Receptors, Platelet-Derived Growth Factor; Signal Transduction; Sorafenib | 2014 |
Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.
Topics: Animals; Carbon Tetrachloride; Drug Carriers; Human Umbilical Vein Endothelial Cells; Lactic Acid; Liver; Liver Cirrhosis; Male; Mice; Nanoparticles; Niacinamide; Phenylurea Compounds; Polyethylene Glycols; Polyglactin 910; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Protein Kinase Inhibitors; Sorafenib | 2016 |
Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis.
Topics: Animals; Apoptosis; Bile Ducts; Carbon Tetrachloride; Cell Line; Cell Proliferation; Disease Models, Animal; Hepatic Stellate Cells; Humans; Ligation; Liver Cirrhosis; Male; Mice, Inbred C57BL; Mutation; Phenyl Ethers; Phenylurea Compounds; Protein Domains; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Rats; Sorafenib; STAT3 Transcription Factor | 2017 |
Sorafenib Attenuates Fibrotic Hepatic Injury Through Mediating Lysine Crotonylation.
Topics: Animals; Carbon Tetrachloride; Liver; Liver Cirrhosis; Lysine; Male; Rats; Rats, Sprague-Dawley; Sorafenib | 2022 |